Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Alphamab Co Ltd (9966 HK)
Watchlist
103
Analysis
Health Care
•
China
Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Alphamab Co Ltd
•
08 Dec 2019 13:19
ECM Weekly (8 Dec 2019) - OneConnect, JS Global, Renrui, Poly Property, Freee, Burger King India
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This...
Zhen Zhou, Toh
454 Views
Share
bullish
•
Alphamab Co Ltd
•
03 Dec 2019 01:53
Alphamab Oncology IPO: Valuation Easy to Swallow
Alphamab Co Ltd (9966 HK) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
Arun George
Follow
534 Views
Share
bullish
•
Venus MedTech
•
01 Dec 2019 11:18
ECM Weekly (1 Dec 2019) - Venus Medtech, Alphamab, CMC REIT, XD, BAM
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. It has...
Zhen Zhou, Toh
460 Views
Share
bullish
•
Alphamab Co Ltd
•
29 Nov 2019 14:00
Alphamab (康宁杰瑞) IPO: You Will Likely Be Zeroed
Alphamab launched book building to raise up to USD 234 million to list in Hong Kong. In our previous notes, we covered the company’s key pipeline...
Ke Yan, CFA, FRM
Follow
567 Views
Share
bullish
•
Alphamab Co Ltd
•
28 Nov 2019 16:23
Alphamab Oncology IPO Initiation: Clear Diagnosis
Alphamab Co Ltd (1728643D CH) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
Arun George
Follow
484 Views
Share
First
Previous
16
17
18
19
20
21
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x